‘Incredibly excited’: Richard Scolyer hails new US trial for brain cancer

It is the news that former Australian of the Year Professor Richard Scolyer has been hoping to hear ever since he started an experimental treatment for brain cancer more than 2½ years ago: a world-first clinical trial to determine whether it can revolutionise the approach to glioblastoma has opened in the United States.

Australian medical oncologist Professor Mustafa Khasraw, from Duke University in North Carolina, is leading the trial to see whether immunotherapy drugs can help patients diagnosed with the same lethal brain tumour as the world-renowned pathologist and researcher.

“I’m incredibly excited that this trial has commenced,” Scolyer said. “It takes a long time to get trials over the line but to be actually recruiting patients in the United States – and hopefully here soon – means we can test out the drugs to see if they make a difference.”

Duke will join four other cancer centres in Los Angeles, San Francisco, Houston and New York in the two-stage trial.

https://www.theage.com.au/lifestyle/health-and-wellness/incredibly-excited-richard-scolyer-hails-new-us-trial-for-brain-cancer-20260210-p5o12b.html

https://archive.md/Kou9i